Kenya Endorses Communique on Advancing Health Products Manufacturing
African Union (AU) Member States have endorsed a communiqué aimed at strengthening local manufacturing of vaccines, diagnostics, medicines, and other essential health products.
Kenya's delegation, led by Principal Secretary for Medical Services Harry Kimtai, joined regional leaders in supporting key commitments to enhance health security and self-sufficiency across the continent.
The communiqué highlights the upgrade of the Partnerships for African Vaccine Manufacturing (PAVM) to the Platform for Harmonized African Health Manufacturing (PHAHM) to drive self-reliance, the establishment of the African Pooled Procurement Mechanism (APPM) to improve affordability and access, and the strengthening of regulatory frameworks through the African Medicines Regulatory Harmonization (AMRH) and the African Medicines Agency (AMA).
It also supports the Gavi African Vaccine Manufacturing Accelerator (AVMA), a $1.2 billion initiative to boost vaccine production, while promoting regional collaboration and financing mechanisms to sustain investments in Africa's health manufacturing sector.
The forum urged AU Member States, regional economic communities, and global partners to prioritize procurement of African-made vaccines and health products to ensure demand certainty for local manufacturers.
It also called for stronger commitments to talent development, financing, and coordinated procurement strategies to reduce import dependency. Kenya reaffirmed its commitment to advancing these initiatives, aligning with the AU's vision for a resilient and self-reliant health system across the continent.
Distributed by APO Group on behalf of Ministry of Health, Kenya.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
5 days ago
- Zawya
A Call to Action to End Cholera in Africa by 2030
On 4 June 2025, twenty African Union Member States most affected by cholera convened for an extraordinary high-level meeting, following a call by Africa CDC and under the leadership of H.E. President Hakainde Hichilema, AU Champion on Cholera. This historic gathering of Heads of State and Government marked a turning point in the fight against cholera across the continent. Leaders endorsed a unified Call-to-Action to eliminate cholera in Africa by 2030—anchored in national ownership, local vaccine production, integrated WASH systems, and coordinated continental response. Africa CDC is committed to supporting Member States and partners to turn this political resolve into measurable action, securing Africa's health sovereignty and ending cholera once and for all. Download the Call-to-Action here. Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).
Zawya
6 days ago
- Zawya
African Leaders, Africa Centres for Disease Control and Prevention (Africa CDC), and Partners Unite in Bold Drive to Fight Cholera
In a historic demonstration of political resolve and continental unity, twenty African Union (AU) Member States affected by cholera convened on 4 June 2025 for a high-level virtual meeting, following a call by the Africa Centres for Disease Control and Prevention (Africa CDC) and under the leadership of H.E. Hakainde Hichilema, President of Zambia and AU Champion on Cholera. The meeting brought together ten Heads of State and Vice-Presidents—representing Angola, Zambia, the Democratic Republic of Congo, Namibia, Ghana, Malawi, Mozambique, South Sudan, Tanzania, and Zimbabwe—alongside Deputy Prime Ministers, Ministers of Health, Finance, and Water and Sanitation. Global health partners, including WHO, UNICEF, Gavi, the Global Fund, and others, also participated to forge a united front in the fight against cholera. As of May 2025, Africa has reported approximately 130,000 cholera cases and 2,700 deaths, representing 60% of global reported cases and an alarming 93.5% of cholera-related deaths. Angola, the DRC, Sudan, and South Sudan remain among the most severely affected. In his opening address, H.E. Mahmoud Ali Youssouf, Chairperson of the African Union Commission, called for bold leadership and systemic change: 'The people of Africa are watching. They expect bold, coordinated, and unwavering leadership that puts their health and dignity first. This crisis demands action at the highest political level. Only through the direct engagement of our Heads of State can we drive the elimination of cholera by 2030. This requires a continental shift—strong national leadership, domestic investment, integrated national actions, and regional coordination. We must also break the cycle of dependency by accelerating vaccine manufacturing and ensuring equitable access to life-saving tools.' H.E. João Manuel Gonçalves Lourenço, President of Angola and Chairperson of the African Union, underscored the need for transformative investments: 'To tackle this disease, we must invest robustly in water, sanitation, and health systems. This is our moment to turn historic challenges into real opportunities for economic and social development.' Dr. Jean Kaseya, Director General of Africa CDC, emphasized the systemic drivers of the crisis—limited WASH infrastructure, insecurity, weak coordination, and vaccine shortages: 'Africa needs 54 million doses of oral cholera vaccine annually but receives barely half. This gap is unacceptable. Urgent action is needed to scale up local production and secure supply.' Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, welcomed the leadership shown: 'I commend the Heads of State for their vision and commitment. WHO will intensify its support to affected countries through this Call to Action.' African leaders committed to operationalizing the Continental Incident Management Support Team (IMST), building on the successful mpox response, to reinforce cross-border surveillance. At the national level, they pledged to establish Presidential Task Forces on Cholera to strengthen multisectoral coordination, mobilize domestic resources, and enforce accountability frameworks. They further emphasized scaling up local vaccine manufacturing, expanding WASH infrastructure, and deepening partnerships with the private sector. Etleva Kadili, UNICEF Regional Director for Eastern and Southern Africa, reminded leaders that children are most affected: 'Children bear the brunt of this crisis. Bold action and unwavering political will are urgently needed.' Dr. Sania Nishtar, CEO of Gavi, reported significant improvements in vaccine availability—from 2 million doses in 2013 to over 21 million in 2025—and the delivery of 1.9 million rapid diagnostic kits to support outbreak detection. She reaffirmed Gavi's commitment to supporting local manufacturing in Africa through the African Vaccine Manufacturing Accelerator (AVMA) and urged global support for Gavi's upcoming replenishment. In closing, H.E. Hakainde Hichilema reaffirmed his commitment to report back to the AU Assembly on progress: 'We have issued a clear Call to Action. Now we must deliver—through scaled-up domestic investments, strengthened cross-border coordination, and community-driven responses. Africa needs one continental IMST, one community-centered plan, and one accountability framework.' The meeting marks a turning point in Africa's response to cholera—anchored in high-level political ownership, multisectoral collaboration, and continental solidarity. Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).
Zawya
18-05-2025
- Zawya
New Advisory Group on Surveillance to Boost Africa's Health Security
Improvements in the forecasting, monitoring, identification, and reporting of diseases are expected to take hold following the establishment of the Continental Surveillance Advisory Group (CSAG), aimed at bolstering Africa's disease surveillance capabilities. This was among the key outcomes of a meeting hosted from 23 to 25 April 2025 by the Africa Centres for Disease Control and Prevention (Africa CDC), which brought together surveillance directors from 47 African Union Member States. The meeting led to the identification of priority pathogens, including emerging and re-emerging diseases like mpox and cholera, as well as other diseases targeted for eradication. It also resulted in the development of a roadmap to strengthen indicator-based surveillance at Africa CDC. These initiatives support Africa CDC's core mandate to monitor public health events across the continent, driving informed and timely public health actions. They also represent a significant step in evolving the institution's surveillance system, focusing on proactive surveillance, intelligence gathering, and early warning systems, key elements of its five-year strategic roadmap. The CSAG will play a crucial role in guiding Africa CDC's development and implementation of this enhanced surveillance strategy. 'Data quality, timeliness, and completeness remain major challenges in Africa, posing serious limitations to countries and regional institutions in making better analyses or informed decisions and allocating resources,' said Dr Merawi Aragaw, Head of the Surveillance and Disease Intelligence Division at Africa CDC. To address these challenges, efforts are underway to strengthen surveillance systems on multiple fronts, including coordination, disease forecasting, monitoring, evaluation, and leveraging data for targeted public health actions and optimised resource allocation. Despite progress in event-based surveillance, case-based and indicator-based systems remain underdeveloped at the continental level, highlighting the critical need for a more integrated and resilient surveillance infrastructure. Dr Allan Muruta, the newly elected CSAG Chairperson and Commissioner of Integrated Epidemiology, Surveillance, and Public Health Emergencies for Uganda, emphasised the importance of collaboration. 'During my term, advocating for the implementation of surveillance standards and advancing digitalisation and health information exchange will be central to our efforts in fostering a healthy and prosperous Africa,' he said. Africa CDC will continue collaborating with surveillance experts across the continent and the CSAG to develop a strategic framework that guides improvements in indicator-based surveillance. Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).
